Safety advantages of topical versus oral nonsteroidal antiinflammatory drugs

Journal of Rheumatology

Volumn 38, Issue 3, 2011, Pages 572-

  Altman, Roy D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; WARFARIN;

APPLICATION SITE REACTION; CARDIOVASCULAR DISEASE; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY DISEASE; KNEE OSTEOARTHRITIS; LETTER; LUNG EMBOLISM; NAUSEA; OSTEOARTHRITIS; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; GASTROINTESTINAL HEMORRHAGE; HUMANS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79952383227     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100748     Document Type: Letter

References (11)

1. Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: A systematic literature review. J Rheumatol 2010;37:1236-43.
2. Baraf HS, Gold M, Clark MB, Altman RD. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: A randomized controlled trial. Phys Sportsmed 2010;38:19-28.
3. Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum 2009;39:203-12.
4. Barthel HR, Petruschke RA, Gold MS, Wieman MS. Safety of diclofenac sodium 1% gel for knee osteoarthritis in patients aged ≥ 65 years with comorbidities. American Medical Directors Association Long Term Care Medicine 2010, March 11-14, 2010; Long Beach, CA.
5. Gloth FM, Petruschke RA, Gold MS, Wieman MS. Safety and efficacy of diclofenac sodium 1% gel for knee osteoarthritis in patients with comorbidities [poster]. American Pain Society Annual Scientific Meeting, May 6-8, 2010; Baltimore, MD.
6. Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:1991-9.
7. Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial. BMC Musculoskelet Disord 2005;6:44.
8. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med 2004;164:2017-23. (Pubitemid 39390559)
9. Simon LS, Grierson LM, Naseer Z, Bookman AA, Shainhouse ZJ. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009;143:238-45.
10. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004;31:2002-12. (Pubitemid 39336727)
11. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.